PHVSPharvaris N.V.
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Choppy, but holding above its 200-day average. Oversold (RSI 18). Price is +4% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Lightly shorted, settled Sep 15, 2026, a few days of normal trading to cover. Down 17% since the previous count, up from 1.5% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PHVS is trading
Pharvaris N.V. is +23% over the past year while the S&P 500 is +18%: 4.5 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +3.8%
vs 200-day average · close to trend
- RSI (14)
- 18
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 20%
Below its 52-week high
Details›
- Last close2026-10-09
- $31.14
- 1 monthS&P 500 +2.7%
- −17%
- 1 yearS&P 500 +18%
- +23%
- 5 yearsS&P 500 +88%
- +64%
- vs 50-day average$34.73
- −10%
- 52-week high
- $38.97
- 52-week low
- $20.96
- Annualised volatility
- 60%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$18M
| Year | Return |
|---|---|
| 2026 (year to date) | +12% |
| 2025 | +45% |
| 2024 | −32% |
| 2023 | +149% |
| 2022 | −22% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 2 of 5 | −0.93% |
| Feb | 5 | 1 of 5 | −7.7% |
| Mar | 6 | 2 of 6 | −3.6% |
| Apr | 6 | 4 of 6 | +5.1% |
| May | 6 | 1 of 6 | −8.9% |
| Jun | 6 | 4 of 6 | +18% |
| Jul | 6 | 3 of 6 | +2.0% |
| Aug | 6 | 5 of 6 | −1.2% |
| Sep | 6 | 3 of 6 | −2.7% |
| Oct | 6 | 1 of 6 | −6.3% |
| Nov | 5 | 2 of 5 | −11% |
| Dec | 5 | 2 of 5 | +96% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.